Metformin: an old but still the best treatment for type 2 diabetes.
about
The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapiesTraumatic injuries in patients with diabetes mellitusMetformin: An Old Drug for the Treatment of Diabetes but a New Drug for the Protection of the EndotheliumMetformin and metabolic diseases: a focus on hepatic aspectsUnderstanding and overcoming metformin gastrointestinal intolerance.Evaluation Series on Safety and Efficacy of Nutritional Supplements in Newly Diagnosed Hyperglycemia: A Placebo-Controlled, Randomized Study.Optimal therapy of type 2 diabetes: a controversial challengeLack of Effects of Metformin and AICAR Chronic Infusion on the Development of Hypertension in Dahl Salt-Sensitive RatsLinagliptin improves endothelial function in patients with type 2 diabetes: A randomized study of linagliptin effectiveness on endothelial function.Metabolic and Biochemical Stressors in Diabetic Cardiomyopathy.Metformin intake associates with better cognitive function in patients with Huntington's disease.Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon-like peptide-1 receptor agonists: Higher adherence and persistence with dulaglutide compared with once-weekly exenatide and liraglutideEffectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study.MARCH2: comparative assessment of therapeutic effects of acarbose and metformin in newly diagnosed type 2 diabetes patientsCardiovascular impact of drugs used in the treatment of diabetesColorectal and Prostate Cancer Risk in Diabetes: Metformin, an Actor behind the Scene.Metformin is not just an antihyperglycaemic drug but also has protective effects on the vascular endothelium.Metformin use in patients with type 2 diabetes mellitus is associated with reduced risk of deep vein thrombosis: a non-randomized, pair-matched cohort study.Comparative efficacy of glimepiride and metformin in monotherapy of type 2 diabetes mellitus: meta-analysis of randomized controlled trialsEpidemiology and management of antiretroviral-associated cardiovascular disease.Effect of Metformin on Viability, Morphology, and Ultrastructure of Mouse Bone Marrow-Derived Multipotent Mesenchymal Stromal Cells and Balb/3T3 Embryonic Fibroblast Cell Line.Pharmacotherapy for Hyperglycemia in Noncritically Ill Hospitalized PatientsMetformin Changes the Relationship between Blood Monocyte Toll-Like Receptor 4 Levels and Nonalcoholic Fatty Liver Disease-Ex Vivo StudiesAblation of XP-V gene causes adipose tissue senescence and metabolic abnormalities.The influence of goutweed (Aegopodium podagraria L.) tincture and metformin on the carbohydrate and lipid metabolism in dexamethasone-treated rats.Beneficial Effects of Metformin and/or Salicylate on Palmitate- or TNFα-Induced Neuroinflammatory Marker and Neuropeptide Gene Regulation in Immortalized NPY/AgRP NeuronsSimultaneous Quantification of Antidiabetic Agents in Human Plasma by a UPLC-QToF-MS MethodAssociation of APOE polymorphisms with diabetes and cardiometabolic risk factors and the role of APOE genotypes in response to anti-diabetic therapy: results from the AIDHS/SDS on a South Asian population.Metformin Is a Substrate and Inhibitor of the Human Thiamine Transporter, THTR-2 (SLC19A3).Vitamin C further improves the protective effect of GLP-1 on the ischemia-reperfusion-like effect induced by hyperglycemia post-hypoglycemia in type 1 diabetes.The Effect of Dolutegravir on the Pharmacokinetics of Metformin in Healthy Subjects.Saxagliptin and metformin in fixed combination for the treatment of type 2 diabetes in adultsAn overview of the effect of sodium glucose cotransporter 2 inhibitor monotherapy on glycemic and other clinical laboratory parameters in type 2 diabetes patientsComparative anti-inflammatory and lipid-normalizing effects of metformin and omega-3 fatty acids through modulation of transcription factors in diabetic rats.Metformin Prevents Dopaminergic Neuron Death in MPTP/P-Induced Mouse Model of Parkinson's Disease via Autophagy and Mitochondrial ROS ClearanceDoes Glucagon-like Peptide-1 Ameliorate Oxidative Stress in Diabetes? Evidence Based on Experimental and Clinical Studies.Hormonal signaling in the gut.Clinical relevance of target identity and biology: implications for drug discovery and development.Metformin in the treatment of non-alcoholic fatty liver disease: safety, efficacy and mechanism.Cellular reprogramming for pancreatic β-cell regeneration: clinical potential of small molecule control.
P2860
Q26744317-392149FD-E183-4F06-90FF-4C2DED720A35Q26751033-D25E63B7-844B-4814-BA1F-A27936D12AA8Q26999344-3338568C-3FEE-43F5-83CD-071B05B89442Q28082736-027CB4A9-8ABB-4F24-A373-E66A3B8B7E49Q30240030-097554B3-5A31-4307-9CD3-C4BEA71AB773Q30386420-F98F7864-940A-489E-A2F8-EE7741A055FFQ33577712-EC3B76D6-A9E8-4966-BC8E-FDC06844E698Q33581391-62393CA9-CAA4-437D-919E-3D21DAA44A08Q33633664-E6CCF100-0DD1-4E9B-8183-F45780088F98Q33740554-9F95F1FF-3CD6-4E55-B4A3-8157190A88FDQ33817346-3883749B-02AE-4AA8-ADDF-B2660FB11825Q33835762-939D25B1-1CAF-4528-99CA-8B78F04AC374Q33882438-3E8DCCC6-C80F-48FC-B9C6-EA522D531344Q34078741-B33B84CC-529B-4368-9390-2209C7BBE19EQ34383575-7DD02C55-5A1E-4A4A-BBF0-614E56BB1D51Q34438700-4594FD11-B487-4B35-94B1-A7E3029C3C4AQ34505650-DB12CD8E-7C1A-45F5-902E-E6EE136EA891Q34762025-B67B0A5C-A107-4425-8402-9071C43AB95CQ35042504-1F18E915-947C-4CAC-B196-34D132075A41Q35338096-92532C08-5F62-4483-BACB-2AFFEB3CD763Q35603449-A5C14968-3ADB-4B3B-811C-CA1100ADEB7EQ35912987-D9F2C1F2-471C-4319-B035-0E5CFAD9C91AQ35941446-3D6AA682-9257-4D9F-9742-405CEA6E970BQ35989743-0F6043D1-2729-4B35-9966-E208C4A53A5CQ36083762-C1801803-0031-4003-82E4-31CECE7DDB5DQ36205527-854994A0-90E1-43BA-A1DF-A0F0764F6A99Q36216123-E2BB8B29-7F6D-438C-86AE-6DC82C7E8D05Q36307711-9DACB4D6-5754-4DDF-B652-5728C294AC70Q36709745-699E5526-A165-49FC-9852-BEB640A2D3B5Q36976130-3E4A68F4-4D4B-4CD8-BA4B-3E348F81FED1Q37071977-6F36CD7D-09D6-4A5E-AA38-345D879A00C9Q37082630-AD551B62-24B9-4551-A339-33DBE154B640Q37114983-0E30F1FD-E0A4-4AFA-9D46-3CB6D81B405BQ37142039-7F494320-FEAC-4CAB-8C59-A82DC86F97CBQ37299382-C43CC194-53C9-4F3F-8362-D6664C6EFE26Q37402790-92710EF9-7602-4CE1-A881-526805A98782Q37727577-05E535D0-DFBB-496D-A23B-C1B3A71326A6Q38147723-AE330C65-2F1E-456A-8857-D8103DD36037Q38192049-6A8F5742-65EB-4509-9233-DC96996F49A0Q38200150-B677730F-FD20-4978-ACB4-1CD79D54B405
P2860
Metformin: an old but still the best treatment for type 2 diabetes.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Metformin: an old but still the best treatment for type 2 diabetes.
@ast
Metformin: an old but still the best treatment for type 2 diabetes.
@en
type
label
Metformin: an old but still the best treatment for type 2 diabetes.
@ast
Metformin: an old but still the best treatment for type 2 diabetes.
@en
prefLabel
Metformin: an old but still the best treatment for type 2 diabetes.
@ast
Metformin: an old but still the best treatment for type 2 diabetes.
@en
P2860
P356
P1476
Metformin: an old but still the best treatment for type 2 diabetes.
@en
P2093
Lilian Beatriz Aguayo Rojas
Marilia Brito Gomes
P2860
P2888
P356
10.1186/1758-5996-5-6
P577
2013-02-15T00:00:00Z
P5875
P6179
1015729013